Concepedia

Cheryl A. Rizzo

CA

18

Publications

2K

Citations

15

H-Index

1991

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Germany)

Albany Molecular Research (United States)

Cheryl A. Rizzo is an author at Bristol-Myers Squibb (United States) specializing in medicine, drug discovery, and pharmacology.

Top concepts

Publications per year

1991–2016

18

Publications

18

Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/Rel family

Falk Weih, Daniel R. Carrasco, Stephen K. Durham et al. · Cell · 1995 · 801 citations · Full text

, , +16

Nuclear Factor (NF)-κB2 (p100/p52) Is Required for Normal Splenic Microarchitecture and B Cell–mediated Immune Responses

Jorge Caamaño, Cheryl A. Rizzo, Stephen K. Durham et al. · The Journal of Experimental Medicine · 1998 · 394 citations · Full text

The androgen receptor can signal through Wnt/β-Catenin in prostate cancer cells as an adaptation mechanism to castration levels of androgens

Liang Schweizer, Cheryl A. Rizzo, Thomas Spires et al. · BMC Cell Biology · 2008 · 114 citations · Full text

Both products of the fosB gene, FosB and its short form, FosB/SF, are transcriptional activators in fibroblasts.

P Dobrazanski, T Noguchi, Karla Kovary et al. · Molecular and Cellular Biology · 1991 · 97 citations · Full text

, , +16

The pharmacology of SCH 50911: a novel, orally-active GABA-beta receptor antagonist.

Donald C. Bolser, David J. Blythin, Richard W. Chapman et al. · Journal of Pharmacology and Experimental Therapeutics · 1995 · 77 citations

Rows per page

1–5 of 18